Healthcare stakeholder panel session at CHPA annual executive conference
FDA Grants ADI-001 Fast Track Designation as Treatment of Refractory Systemic Lupus Erythematosus
ADI-001 is an investigation allogeneic gamma delta chimeric antigen receptor T cell therapy that targets CD20 for the treatment of a variety of autoimmune diseases.
American Pharmacies: Powering the Profession Through Leadership
Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.
Q&A: How Pharmacists Can Use AI to Humanize Care
Scott Nelson, PharmD, MS, FAMIA, ACHIP, joined Drug Topics to discuss the 2025 Pharmacy Forecast and AI’s role in the future of pharmacy practice.
How Centralized Fulfillment is Making Pharmacy More Efficient
Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.
Digital Education Games Could Help Improve Diabetes Management in Children
Children with type 1 diabetes who watched educational videos and played games had improved glycemic control and quality of life.
RFK Jr Says Trump Administration ‘Committed’ to PBM Reform
As a new presidential administration begins to take shape, experts are curious about its promises of potential PBM reform within the pharmacy benefits industry.
